Orgenesis Inc. announced that Mario Philips was appointed to Board of Directors. In that role, he was responsible for developing and executing all business strategies, including the introduction of new products and service solutions for the life sciences industry. Mario Philips is Chief Executive Officer of PolyNeuroS, a drug company based in France that has developed a diagnostic platform technology for neurodegenerative diseases in combination with a therapy to cure neurodegenerative diseases such as ALS and Parkinson’s. Mr. Philips also acts as strategic partner for the private equity fund, Archimed, and is Chairman of the Board for its portfolio company, Clean Biologics.